In line with this, patients with breast cancer expressing p53γ along with mutant p53 had a similar prognosis as those with WT-p53, whereas those who were devoid of p53γ and expressed only mutant p53 showed markedly poor prognosis (35). This evidence concerns the gene TP53 and breast cancer.